Skip to main content
logo
Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.719
+0.019 (0.40%)
At close: Jun 27, 2025, 4:00 PM
4.700
-0.019 (-0.40%)
After-hours: Jun 27, 2025, 4:00 PM EDT

Radiopharm Theranostics Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
1.680.30.29--
Other Revenue
-1.351.665.92--
Revenue
0.331.966.21--
Revenue Growth (YoY)
-94.50%-68.46%---
Cost of Revenue
21.7221.6119.537.49-
Gross Profit
-21.38-19.65-13.32-7.49-
Selling, General & Admin
12.8413.0412.237.640.3
Operating Expenses
14.6815.6815.2712.441.16
Operating Income
-36.07-35.33-28.59-19.93-1.16
Interest Expense
-0.61-0.64-0.09-9.35-
Interest & Investment Income
0.050.050.150.01-
Currency Exchange Gain (Loss)
0.690.09-0.26-1.11-0
EBT Excluding Unusual Items
-35.94-35.83-28.79-30.38-1.16
Gain (Loss) on Sale of Assets
-1.69-1.69---
Asset Writedown
-1.48-1.48-3.1--
Other Unusual Items
-3.56-8.86-2.68--
Pretax Income
-42.67-47.85-34.57-30.38-1.16
Income Tax Expense
0.170.10.040.04-
Net Income
-43-47.95-34.61-30.42-1.16
Net Income to Common
-43-47.95-34.61-30.42-1.16
Shares Outstanding (Basic)
1,140386306181-
Shares Outstanding (Diluted)
1,140386306181-
Shares Change (YoY)
243.78%26.36%68.74%--
EPS (Basic)
-0.04-0.12-0.11-0.17-
EPS (Diluted)
-0.04-0.12-0.11-0.17-
Free Cash Flow
-33.42-22.98-23.25-9.91-0.08
Free Cash Flow Per Share
-0.03-0.06-0.08-0.06-
Gross Margin
---214.52%--
Operating Margin
-10908.64%-1803.82%-460.41%--
Profit Margin
-13006.38%-2448.23%-557.36%--
Free Cash Flow Margin
-10107.88%-1173.12%-374.36%--
EBITDA
-32.99-32.2-25.29-16.94-
D&A For EBITDA
3.073.133.32.98-
EBIT
-36.07-35.33-28.59-19.93-1.16
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q